subject area of
- ARIA‐EAACI statement on asthma and COVID‐19 (June 2, 2020) Academic Article
- Analysis of the susceptibility of lung cancer patients to SARS-CoV-2 infection Academic Article
- Angiotensin-converting enzyme 2 (ACE2) levels in relation to risk factors for COVID-19 in two large cohorts of patients with atrial fibrillation Academic Article
- Angiotensin-converting enzyme 2 expression in COPD and IPF fibroblasts: the forgotten cell in COVID-19 Academic Article
- Broad and Differential Animal Angiotensin-Converting Enzyme 2 Receptor Usage by SARS-CoV-2 Academic Article
- Cabbage and fermented vegetables: From death rate heterogeneity in countries to candidates for mitigation strategies of severe COVID‐19 Academic Article
- Correlation of SARS-CoV-2 Viral Neutralizing Antibody Titers with Anti-Spike Antibodies and ACE-2 Inhibition among Vaccinated Individuals Academic Article
- Gene expression and in situ protein profiling of candidate SARS-CoV-2 receptors in human airway epithelial cells and lung tissue Academic Article
- Identification of residues in the receptor-binding domain (RBD) of the spike protein of human coronavirus NL63 that are critical for the RBD–ACE2 receptor interaction Academic Article
- Immunogenicity of Extended mRNA SARS-CoV-2 Vaccine Dosing Intervals Academic Article
- Impact of ACE2 gene polymorphism on antihypertensive efficacy of ACE inhibitors Academic Article
- Increased Urinary Angiotensin-Converting Enzyme 2 in Renal Transplant Patients with Diabetes Academic Article
- Plasma ACE2 and risk of death or cardiometabolic diseases: a case-cohort analysis Academic Article
- Role of Human Antigen R (HuR) in the Regulation of Pulmonary ACE2 Expression Academic Article
- The ocular surface, coronaviruses and COVID‐19 Academic Article